公开(公告)号：US20240327879A1

公开(公告)日：2024-10-03

申请号：US18741273

申请日：2024-06-12

Applicant: S&P Ingredient Development, LLC

Inventor： Paul Blum ,  Sambasiva Rao Chigurupati ,  Derrick Jermaine White

IPC: C12P7/52 ,  C12N1/20 ,  C12R1/02 ,  C12R1/145 ,  C12R1/225

CPC classification number: C12P7/52 ,  C12N1/205 ,  C12R2001/02 ,  C12R2001/145 ,  C12R2001/225

Abstract: Microbial cell lines suitable for industrial-scale production of organic acids and methods of making and isolating such cell lines, and using the cell lines for production of organic acids.

公开(公告)号：US20240318205A1

公开(公告)日：2024-09-26

申请号：US18417981

申请日：2024-01-19

Applicant: Renescience A/S

Inventor： Georg Ørnskov Rønsch ,  Jacob Wagner Jensen ,  Sebastian Buch Antonsen

IPC: C12P5/02 ,  B09B3/00 ,  B09B5/00 ,  C02F3/34 ,  C02F11/04 ,  C12N1/20 ,  C12P7/08 ,  C12P7/56 ,  C12P7/62 ,  C12P19/02 ,  C12P19/14 ,  C12R1/01 ,  C12R1/04 ,  C12R1/07 ,  C12R1/08 ,  C12R1/10 ,  C12R1/125 ,  C12R1/225

CPC classification number: C12P5/023 ,  B09B3/00 ,  B09B5/00 ,  C02F11/04 ,  C12N1/20 ,  C12N1/205 ,  C12P7/08 ,  C12P7/56 ,  C12P7/62 ,  C12P19/02 ,  C12P19/14 ,  C02F3/342 ,  C12R2001/01 ,  C12R2001/04 ,  C12R2001/07 ,  C12R2001/08 ,  C12R2001/10 ,  C12R2001/125 ,  C12R2001/225 ,  Y02E50/30

Abstract: The invention provides a method of processing MSW comprising the steps of—providing a stream of unsorted MSW to a microbial fermentation reactor in which the MSW is fermented with agitation at a non-water content of between 10 and 50% by weight and at a temperature of between 35 and 75 degrees C. for a period of between 1 and 72 hours under conditions sufficient to maintain a live lactic acid bacteria concentration of at least 10,000,000,000 CFU/L, and—removing a stream of fermented unsorted MSW from the reactor and subjecting it to a separation step whereby non-degradable solids are removed to provide a slurry of biodegradable components. Further, a slurry of bio-degradable components prepared according to said method is provided.

公开(公告)号：US20240307468A1

公开(公告)日：2024-09-19

申请号：US18419725

申请日：2024-01-23

Applicant: LACTOMASON CO., LTD. ,  BINGGRAE CO., LTD.

Inventor： Minn SOHN ,  Je Seong PARK ,  Ye Ji YOU ,  Young Sup SHIN ,  Sung Hwan KIM ,  Chul Hong KIM

IPC: A61K35/747 ,  A23C9/123 ,  A61K35/744 ,  A61K35/745 ,  C12N1/20 ,  C12R1/225

CPC classification number: A61K35/747 ,  A23C9/1234 ,  A61K35/744 ,  A61K35/745 ,  C12N1/205 ,  A23V2400/113 ,  A23V2400/123 ,  A23V2400/175 ,  A23V2400/249 ,  A23V2400/531 ,  C12R2001/225

Abstract: The present disclosure relates to an immune-enhancing composition comprising Lactobacillus rhamnosus LM1019 and starter strains. An immune-enhancing composition comprising Lactobacillus rhamnosus LM1019 and starter strains according to the present disclosure has an excellent immune-enhancing effect by increasing the amount of nitric oxide (NO) produced and improving the TNF-α secretion ability. Also, since the immune-enhancing composition contains the starter strain, it can be used to produce fermented milk. Under the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, the Lactobacillus rhamnosus LM1019 strain was deposited with the international depositary authority: the Korean Culture Center of Microorganisms (KCCM) on Aug. 11, 2017, under the Accession Number: KCCM12308P.

公开(公告)号：US11992511B2

公开(公告)日：2024-05-28

申请号：US17673460

申请日：2022-02-16

Applicant: KoBioLabs, Inc.

Inventor： Gwang Pyo Ko ,  Woonki Kim ,  You-Jin Jang ,  Boram Seo ,  June-Chul Lee ,  Tae-Wook Nam ,  Insu Kim ,  Jin-Woo Lee

IPC: A61K35/747 ,  A23L33/00 ,  A23L33/135 ,  A61P1/00 ,  A61P37/08 ,  C12N1/20 ,  A61K35/00 ,  C12R1/225

CPC classification number: A61K35/747 ,  A23L33/135 ,  A23L33/40 ,  A61P1/00 ,  A61P37/08 ,  C12N1/20 ,  C12N1/205 ,  A23V2002/00 ,  A23V2400/165 ,  A61K2035/115 ,  C12R2001/225

Abstract: Human-derived probiotic strains Lactobacillus paracasei KBL382, Lactobacillus paracasei KBL384 and Lactobacillus paracasei KBL385 are described, as well as uses of the strains for improving intestinal health and treating or preventing intestinal diseases. The strains have excellent anti-inflammatory and immunomodulatory functions, superb strengthening effects on tight junctions of the intestinal tract wall, suppress enteritis-induced weight loss and colon length reduction, thereby exhibiting therapeutic effects for enteritis, and significantly alleviate the symptoms of atopic dermatitis. The strains can be used as probiotic material for enhancing anti-inflammatory effects, strengthening immunity, improving intestinal health functions, and alleviating allergic diseases.

公开(公告)号：US20240166989A1

公开(公告)日：2024-05-23

申请号：US18260850

申请日：2022-01-06

Applicant: Chr. Hansen A/S

Inventor： Thomas Janzen ,  Ditte Christiansen ,  Jesper Broend ,  Victoria Prebner ,  Ilenia Manuguerra ,  Geoffrey Ras

IPC: C12N1/20 ,  A23C9/123 ,  A23C11/10 ,  C12N9/12 ,  C12R1/225 ,  C12R1/46

CPC classification number: C12N1/205 ,  A23C9/1238 ,  A23C11/10 ,  A23C11/106 ,  C12N9/12 ,  C12N9/1205 ,  C12Y207/01006 ,  C12Y207/13003 ,  A23V2400/123 ,  A23V2400/249 ,  C12R2001/225 ,  C12R2001/46

Abstract: The present invention relates to a novel Streptococcus thermophilus strain having improved texturizing properties, compositions comprising said strain as well as fermented products manufactured using said strain.

公开(公告)号：US20240165015A1

公开(公告)日：2024-05-23

申请号：US18283926

申请日：2022-03-24

Applicant: BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

Inventor： Zhen LU ,  Yujie WEI ,  Yuanjun SUN ,  Ranran DU ,  Yan ZHAO ,  Xueping GUO

IPC: A61K8/99 ,  A61Q17/00 ,  C12N1/20 ,  C12P13/04 ,  C12P19/04 ,  C12P21/00 ,  C12R1/225

CPC classification number: A61K8/99 ,  A61Q17/005 ,  C12N1/205 ,  C12P13/04 ,  C12P19/04 ,  C12P21/00 ,  A61K2800/85 ,  C12R2001/225

Abstract: Disclosed are a Lactobacillus rhamnosus strain having accession number CCTCC NO: M 2021185, a ferment lysate prepared thereby for regulating skin microecology, and a preparation method for the ferment lysate. The ferment lysate comprises the following components in mass percentages of same in the ferment lysate: 0.2-1% of proteins, 0.3-0.8% of polysaccharides, and 0.2-1% of amino acids. The ferment lysate obtained by using the above bacterial strain for fermentation can strongly inhibit the reproduction and growth of pathogenic bacteria, has a promotion effect on some of probiotics, has a strong inhibition effect on pathogenic hyphae of Candida albicans, can not only generate antimicrobial peptides during fermentation, but also increase the expression level of antimicrobial peptides in skin cells at the genetic level and the protein level, thereby improving skin immunity.

公开(公告)号：US20240150707A1

公开(公告)日：2024-05-09

申请号：US18412654

申请日：2024-01-15

Applicant: LACTOMASON CO., LTD.

Inventor： Minn SOHN ,  Tae Rahk KIM

IPC: C12N1/20 ,  A61K35/747 ,  A61P15/00 ,  C12R1/225

CPC classification number: C12N1/205 ,  A61K35/747 ,  A61P15/00 ,  C12R2001/225

Abstract: The present disclosure relates to a strain of Lactobacillus gasseri LM1065 (KCCM13018P) and a composition of relieving premenstrual syndrome containing the strain.
A strain of Lactobacillus gasseri LM1065 (KCCM13018P) according to an embodiment of the present disclosure can relieve premenstrual syndrome by reducing NO in blood and TL-6 gene expression and increasing the production ratio of prostaglandin E1/prostaglandin E2 in blood and DGLA levels. Therefore, the strain can be applied to food compositions, health functional food compositions, pharmaceutical compositions, and the like.

公开(公告)号：US20240075083A1

公开(公告)日：2024-03-07

申请号：US18493979

申请日：2023-10-25

Applicant: Quorum Innovations, LLC

Inventor： Nicholas T. MONSUL ,  Eva A. BERKES ,  Frederick T. BOEHM ,  Yu-Hsien LIAO

IPC: A61K35/747 ,  A61K38/16 ,  A61K45/06 ,  A61P31/14 ,  C07K14/335 ,  C12N1/20

CPC classification number: A61K35/747 ,  A61K38/164 ,  A61K45/06 ,  A61P31/14 ,  C07K14/335 ,  C12N1/205 ,  C12R2001/225

Abstract: The subject invention provides compositions and methods for inhibiting viral infections. Preferred embodiments of the invention provide pharmaceutical compositions, and the methods of using the same, comprising a strain of Lactobacillus fermentum bacterium, or bioactive extracts thereof.

公开(公告)号：US20240075082A1

公开(公告)日：2024-03-07

申请号：US18455215

申请日：2023-08-24

Applicant: Bened Biomedical Co., Ltd.

Inventor： Ying-Chieh Tsai ,  Yu-Hsuan Wei ,  Chih-Chieh Hsu ,  Chien-Chen Wu

IPC: A61K35/747 ,  A61K9/00 ,  A61P11/00 ,  A61P37/08 ,  C12N1/20 ,  C12N1/36

CPC classification number: A61K35/747 ,  A61K9/0053 ,  A61P11/00 ,  A61P37/08 ,  C12N1/205 ,  C12N1/36 ,  C12R2001/225

Abstract: Provided is a composition including a lactic acid bacterium and a carrier thereof for prophylaxis or treatment of an allergy. The lactic acid bacterium is Lactobacillus paragasseri, such as Lactobacillus paragasseri BBM171 deposited under DSMZ Accession No. DSM 34311. Also provided is a method for preventing or treating an allergy in a subject that includes administering an effective amount of the composition of Lactobacillus paragasseri to the subject.

公开(公告)号：US11903406B2

公开(公告)日：2024-02-20

申请号：US16574890

申请日：2019-09-18

Applicant: American Snuff Company, LLC

Inventor： Robert S. Reinbold ,  John E. Bunch

IPC: A24B15/20 ,  C12N1/20 ,  C12R1/44 ,  C12R1/225

CPC classification number: A24B15/20 ,  C12N1/205 ,  C12R2001/225 ,  C12R2001/44

Abstract: A method of preparing a tobacco material for use in a smokeless tobacco product is provided, the method including receiving a tobacco material, wherein the tobacco material has not been subjected to a fermentation process, blending the tobacco material with the final moist snuff product ingredients to form a tobacco composition having a moisture content of at least about 50%, packaging the tobacco composition in a final product packaging such that after a fermentation period of 7 to 28 days within the final product packaging the product is ready for direct sale and consumption.